NR1H4 and lung carcinoma: For the bile secretion pathway, Liu et al. 26 reported that bile acid receptor accelerates to the lung cancer process induced by lung fibroblast-tumor cells interaction, with high activation of phosphorylated STAT3 and alteration of cytokine secretion.